CPI SHIPPING ENDOTAK 70/PRX IMPLANTABLE DEFIBRILLATOR SYSTEM
This article was originally published in The Gray Sheet
Executive Summary
CPI SHIPPING ENDOTAK 70/PRX IMPLANTABLE DEFIBRILLATOR SYSTEM following FDA approval on Aug. 5 of the Endotak 70 transvenous lead for use with the company's approved Ventak AICD automatic implantable cardioverter defibrillators. Approval of the lead makes Cardiac Pacemakers, Inc. the second company, behind Medtronic, to bring to the U.S. market a tiered-therapy defibrillator/transvenous lead combination. CPI launched the Ventak PRx implantable pacemaker/cardioverter/defibrillator in June ("The Gray Sheet" June 20, p. 18).